A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study

Peer Review reports

Original Submission
19 Dec 2023	Submitted	Original manuscript
4 Jan 2024	Reviewed	Reviewer Report - Amit Mahipal
18 Mar 2024	Reviewed	Reviewer Report - Masashi Kanai
29 Mar 2024	Author responded	Author comments - Monica Niger
Resubmission - Version 2
29 Mar 2024	Submitted	Manuscript version 2
2 Apr 2024	Reviewed	Reviewer Report - Amit Mahipal
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
2 Apr 2024	Editorially accepted
8 Apr 2024	Article published	10.1186/s12885-024-12225-6

Back to article page